Cognizin® stands out as the original and premium citicoline supplement with a remarkable legacy at the forefront of research exploring the potential benefits of citicoline as a supplement. Embodying Kyowa Hakko’s global standards for excellence, Cognizin® has been pivotal in advancing our understanding of citicoline’s impact on brain health and cognitive performance, and recent clinical studies underscore its impact as a supplement. Extensive research highlights the positive influence of Cognizin® on key cognitive functions — focus, attention, and memory.
Two recent studies examined the effects of Cognizin® on focus and attention. The first study involved middle-aged adults who took 500mg of Cognizin® daily for six weeks, which resulted in heightened brain activity, improved neurotransmission, and enhanced cellular synthesis. In the second study, women and adolescent males who took Cognizin® demonstrated improvements in attention and focus. Specifically, women taking 250mg of Cognizin® daily showed a reduction in both omission and commission errors compared to those taking a placebo.
Another standout study focused on the effects of Cognizin® on memory in healthy older adults. A daily dose of 500mg of Cognizin® was shown to support memory functions for both men and women between the ages of 50 and 85. These findings, evaluated through the widely respected Creyos (formerly known as Cambridge Brain Sciences) standardized test, point toward promising improvements in both episodic and overall memory among individuals incorporating Cognizin® into their daily routine.
This evidence is a continuation of Kyowa Hakko’s commitment to exploring the benefits of citicoline, further establishing it as a viable alternative to synthetic stimulants for those seeking supplements to support overall cognitive health and function. As a leading nootropic ingredient, Cognizin® offers a premium, water-soluble formulation for those looking to seamlessly integrate a brain health ingredient into their products.
Two recent studies examined the effects of Cognizin® on focus and attention. The first study involved middle-aged adults who took 500mg of Cognizin® daily for six weeks, which resulted in heightened brain activity, improved neurotransmission, and enhanced cellular synthesis. In the second study, women and adolescent males who took Cognizin® demonstrated improvements in attention and focus. Specifically, women taking 250mg of Cognizin® daily showed a reduction in both omission and commission errors compared to those taking a placebo.
Another standout study focused on the effects of Cognizin® on memory in healthy older adults. A daily dose of 500mg of Cognizin® was shown to support memory functions for both men and women between the ages of 50 and 85. These findings, evaluated through the widely respected Creyos (formerly known as Cambridge Brain Sciences) standardized test, point toward promising improvements in both episodic and overall memory among individuals incorporating Cognizin® into their daily routine.
This evidence is a continuation of Kyowa Hakko’s commitment to exploring the benefits of citicoline, further establishing it as a viable alternative to synthetic stimulants for those seeking supplements to support overall cognitive health and function. As a leading nootropic ingredient, Cognizin® offers a premium, water-soluble formulation for those looking to seamlessly integrate a brain health ingredient into their products.
